Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1990 Nov;71(3):308–311.

Protection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteins.

I A Rooney 1, B P Morgan 1
PMCID: PMC1384423  PMID: 1702747

Abstract

Cultured human amniotic epithelial cells (HAEC) were found by immunofluorescence microscopy to express three complement inhibitory membrane proteins, CD59 antigen, decay-accelerating factor (DAF) and membrane attack complex (MAC) inhibitory protein (MIP), on their surfaces. The effects of incubation with Fab2 fragments of monoclonal antibodies (mAb) raised against these proteins on susceptibility of sensitized cells to lysis by homologous complement was examined. Percentage cell lysis was markedly increased in the presence of Fab2 anti-CD59 and to a lesser, but significant, extent in the presence of Fab2 anti-DAF. Fab2 anti-MIP did not alter the sensitivity of the cells to lysis by complement.

Full text

PDF
308

Images in this article

309Figure 1
on p.309

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asch A. S., Kinoshita T., Jaffe E. A., Nussenzweig V. Decay-accelerating factor is present on cultured human umbilical vein endothelial cells. J Exp Med. 1986 Jan 1;163(1):221–226. doi: 10.1084/jem.163.1.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burke J., Johansen K. The formation of HL-A antibodies in pregnancy. The antigenicity of aborted and term fetuses. J Obstet Gynaecol Br Commonw. 1974 Mar;81(3):222–228. doi: 10.1111/j.1471-0528.1974.tb00449.x. [DOI] [PubMed] [Google Scholar]
  3. Cederqvist L. L., Ewool L. C., Bonsnes R. W., Litwin S. D. Detectability and pattern of immunoglobulins in normal amniotic fluid throughout gestation. Am J Obstet Gynecol. 1978 Jan 15;130(2):220–224. doi: 10.1016/0002-9378(78)90370-8. [DOI] [PubMed] [Google Scholar]
  4. Curbelo V., Bejar R., Benirschke K., Gluck L. Premature labor. I. Prostaglandin precursors in human placental membranes. Obstet Gynecol. 1981 Apr;57(4):473–478. [PubMed] [Google Scholar]
  5. Daniels R. H., Houston W. A., Petersen M. M., Williams J. D., Williams B. D., Morgan B. P. Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack. Immunology. 1990 Feb;69(2):237–242. [PMC free article] [PubMed] [Google Scholar]
  6. Davies A., Simmons D. L., Hale G., Harrison R. A., Tighe H., Lachmann P. J., Waldmann H. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med. 1989 Sep 1;170(3):637–654. doi: 10.1084/jem.170.3.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Decker T., Lohmann-Matthes M. L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods. 1988 Nov 25;115(1):61–69. doi: 10.1016/0022-1759(88)90310-9. [DOI] [PubMed] [Google Scholar]
  8. Hideshima T., Okada N., Okada H. Expression of HRF20, a regulatory molecule of complement activation, on peripheral blood mononuclear cells. Immunology. 1990 Mar;69(3):396–401. [PMC free article] [PubMed] [Google Scholar]
  9. Huffaker J., Witkin S. S., Cutler L., Druzin M. L., Ledger W. J. Total complement activity in maternal sera, amniotic fluids and cord sera in women with premature labor, premature rupture of membranes or chorioamnionitis. Surg Gynecol Obstet. 1989 May;168(5):397–401. [PubMed] [Google Scholar]
  10. Hänsch G. M., Betz M., Günther J., Rother K. O., Sterzel B. The complement membrane attack complex stimulates the prostanoid production of cultured glomerular epithelial cells. Int Arch Allergy Appl Immunol. 1988;85(1):87–93. doi: 10.1159/000234479. [DOI] [PubMed] [Google Scholar]
  11. Hänsch G. M. The homologous species restriction of the complement attack: structure and function of the C8 binding protein. Curr Top Microbiol Immunol. 1989;140:109–118. doi: 10.1007/978-3-642-73911-8_9. [DOI] [PubMed] [Google Scholar]
  12. López Bernal A., Hansell D. J., Khong T. Y., Keeling J. W., Turnbull A. C. Prostaglandin E production by the fetal membranes in unexplained preterm labour and preterm labour associated with chorioamnionitis. Br J Obstet Gynaecol. 1989 Oct;96(10):1133–1139. doi: 10.1111/j.1471-0528.1989.tb03187.x. [DOI] [PubMed] [Google Scholar]
  13. Medof M. E., Walter E. I., Rutgers J. L., Knowles D. M., Nussenzweig V. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med. 1987 Mar 1;165(3):848–864. doi: 10.1084/jem.165.3.848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Minkoff H. Prematurity: infection as an etiologic factor. Obstet Gynecol. 1983 Aug;62(2):137–144. [PubMed] [Google Scholar]
  15. Morgan B. P., Olavesen M. G., Watts M. J. Presence of a membrane attack complex inhibiting protein on the human epithelial cell line HeLa. Biochem Soc Trans. 1990 Aug;18(4):673–674. doi: 10.1042/bst0180673. [DOI] [PubMed] [Google Scholar]
  16. Nicholson-Weller A., Burge J., Fearon D. T., Weller P. F., Austen K. F. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol. 1982 Jul;129(1):184–189. [PubMed] [Google Scholar]
  17. Nicholson-Weller A., March J. P., Rosen C. E., Spicer D. B., Austen K. F. Surface membrane expression by human blood leukocytes and platelets of decay-accelerating factor, a regulatory protein of the complement system. Blood. 1985 May;65(5):1237–1244. [PubMed] [Google Scholar]
  18. Okita J. R., Sagawa N., Casey M. L., Snyder J. M. A comparison of human amnion tissue and amnion cells in primary culture by morphological and biochemical criteria. In Vitro. 1983 Feb;19(2):117–126. doi: 10.1007/BF02621895. [DOI] [PubMed] [Google Scholar]
  19. Rooney I. A., Morgan B. P. Non-lethal doses of antibody and complement stimulate release of prostaglandin E2 from human amniotic cells in vitro. Biochem Soc Trans. 1990 Aug;18(4):617–617. doi: 10.1042/bst0180617. [DOI] [PubMed] [Google Scholar]
  20. Sugita Y., Nakano Y., Tomita M. Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels. J Biochem. 1988 Oct;104(4):633–637. doi: 10.1093/oxfordjournals.jbchem.a122524. [DOI] [PubMed] [Google Scholar]
  21. Watts M. J., Dankert J. R., Morgan E. P. Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids. Biochem J. 1990 Jan 15;265(2):471–477. doi: 10.1042/bj2650471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Zalman L. S., Wood L. M., Müller-Eberhard H. J. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6975–6979. doi: 10.1073/pnas.83.18.6975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES